Matinas BioPharma Holdings, Inc. (MTNB)
0.8557
-0.07
(-7.69%)
USD |
NYAM |
Nov 17, 16:00
0.8134
-0.04
(-4.94%)
After-Hours: 20:00
Matinas BioPharma Holdings Total Assets (Quarterly) : 4.379M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 4.379M |
| June 30, 2026 | 3.412M |
| March 31, 2026 | 5.874M |
| December 31, 2025 | 7.208M |
| September 30, 2025 | 9.695M |
| June 30, 2025 | 11.42M |
| March 31, 2025 | 12.04M |
| December 31, 2024 | 12.64M |
| September 30, 2024 | 20.58M |
| June 30, 2024 | 24.36M |
| March 31, 2024 | 19.61M |
| December 31, 2023 | 65.58M |
| September 30, 2023 | 29.79M |
| June 30, 2023 | 34.02M |
| March 31, 2023 | 38.26M |
| December 31, 2022 | 78.87M |
| September 30, 2022 | 47.55M |
| June 30, 2022 | 52.42M |
| March 31, 2022 | 55.78M |
| December 31, 2021 | 61.33M |
| September 30, 2021 | 66.98M |
| June 30, 2021 | 69.97M |
| March 31, 2021 | 72.35M |
| December 31, 2020 | 70.97M |
| September 30, 2020 | 74.81M |
| Date | Value |
|---|---|
| June 30, 2020 | 79.09M |
| March 31, 2020 | 84.11M |
| December 31, 2019 | 40.24M |
| September 30, 2019 | 44.82M |
| June 30, 2019 | 48.21M |
| March 31, 2019 | 50.57M |
| December 31, 2018 | 19.94M |
| September 30, 2018 | 14.41M |
| June 30, 2018 | 16.04M |
| March 31, 2018 | 11.49M |
| December 31, 2017 | 14.42M |
| September 30, 2017 | 16.52M |
| June 30, 2017 | 17.80M |
| March 31, 2017 | 22.03M |
| December 31, 2016 | 9.816M |
| September 30, 2016 | 11.31M |
| June 30, 2016 | 5.565M |
| March 31, 2016 | 6.746M |
| December 31, 2015 | 8.406M |
| September 30, 2015 | 9.869M |
| June 30, 2015 | 11.86M |
| March 31, 2015 | 9.798M |
| December 31, 2014 | 3.361M |
| September 30, 2014 | 5.789M |
| June 30, 2014 | 7.363M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.794B |
| Alnylam Pharmaceuticals, Inc. | 7.995B |
| Anika Therapeutics, Inc. | 189.60M |
| Savara, Inc. | 155.93M |
| Arrowhead Pharmaceuticals, Inc. | 1.810B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.451M |
| Shareholders Equity (Quarterly) | 2.928M |
| Debt to Equity Ratio | 0.0014 |
| Current Ratio | 1.776 |
| Net Debt Paydown Yield | 18.01% |